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Letters to the Editorperfusion cannula. Generally we agree
with Mariani and colleagues: a full
percutaneous approach can lower can-
nulation site complications, especially
bleeding, during perfusion. However,
in situations where a safe (ie, ultra-
sound or angiographically controlled)
insertion of a distal perfusion cannula
is not possible or if the perfusion pro-
vided by such is not sufficient, the pre-
sented surgical technique can be
helpful.We do not agreewith the state-
ment that the open technique would
bear higher risks for dissection, lacera-
tion, thrombosis, embolization, arte-
riovenous fistula compared with the
percutaneous technique. In our experi-
ence, the contrary is the case. This is
the reason we insist on a safe and
controlled punction and insertion for
both primary and distal perfusion can-
nulas. Infection of the prosthesis could
theoretically be an issue, however the
rather short duration of arteriovenous
perfusion and the subsequent removal
of the long prosthesis minimize this
risk. In any case, the cannulation site
is monitored by standardized clinical
protocols several times a day.
Both techniques described in
our technical reports1,2 should be
perceived as additional elements in the
armamentarium of a cardiovascular
surgeon. The more alternatives we
have, the better we can serve our
patients, especially in critical
situations.
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AGE OFAN ANIMAL BE
CONSIDERED FOR STUDIES ON
POSTCONDITIONING?
To the Editor:
We have read the great article by
Oosterlinck and colleagues,1 which
showed that ischemic postcondition-
ing (IPostC) reduces the infarct size
and left ventricular impairment in
C57BL6/J mice. The protective ef-
fect of IPostC may be reduced in a
mouse model of the obese diabetic
or metabolic syndrome.1 In their
research, the investigators used 3
different types of mice to measure
the short-term effect of IPostC, but
the gender of the animals was not
described. Several studies showed
that the efficacy of IPostC was
different between male and female
mice.2 In addition, because the
infarct size was smaller in female
rats than in male rats under the
same ischemic conditions,3 it might
be confusing to evaluate the effect
of IPostC. Because of this, gender
should be considered in a study for
evaluating IPostC. We believe that
the gender of the mice used in this
study should be given.
The age of an animal can also affect
the IPostC effect.2,3 Even a minor age
difference in the mice from 14 to 16
weeks to 18 to 20 weeks can
negatively affect the outcome of
IPostC.2 Oosterlinck and colleagues1
used mice at 24 weeks to evaluate
the short-term efficacy of IPostC and
mice at 12 weeks for evaluating
long-term effects. We understand
that the purpose of the study was not
to compare the efficacy in the short
term and long term, but we wonder
why the investigators used 2 different
age groups of animals to study the
short-term and long-term effects of
IPostC.
To show the effect of IPostC on left
ventricular remodeling, the investiga-
tors used cine magnetic resonance im-
aging (cMRI). They compared the
results of cMRI between C56BL/6JCardiovascular Surgery c May 2014and DKOmice at 1 and 10 weeks after
ischemia. Because the myocardial
infarction area after ischemia may
differ in individual animals, we
believe that the results of cMRI should
be compared at 1 and 10 weeks in the
same animal. Comparing the results of
cMRI in the same animal at different
times after ischemia would yield
more accurate results without any
bias caused by differences in the
initial size of the myocardial infarc-
tion area.
In conclusion, we ask 3 questions.
First, whether the investigators used
animals of the same gender? Second,
why did the investigators use different
age groups of animals to evaluate the
short-term and long-term effects of
IPostC? Third, did the investigators
compare the cMRI results at different
time intervals in the same animal, not
between the groups?
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